1 |
Alagawany, M., Y.A. Attia, M.R. Farag, S.S. Elnesr, S.A. Nagadi, M.E. Shafi, A.F. Khafaga, H. Ohran, A.A. Alaqil and M.E. Abd El-Hack. 2021. The strategy of boosting the immune system under the COVID-19 pandemic. Front. Vet. Sci. 7: 570748.
DOI
|
2 |
Bandaru, P., H. Rajkumar and G. Nappanveettil. 2013. The impact of obesity on immune response to infection and vaccine: an insight into plausible mechanisms. Endocrinol. Metab. Synd. 2:2.
|
3 |
Cuadrado, A. and A.R. Nebreda. 2010. Mechanisms and functions of p38 MAPK signalling. Biochem. J. 429(3):403-417.
DOI
|
4 |
Kyriakis, J.M. and J. Avruch. 2012. Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol. Rev. 92(2):689-737.
DOI
|
5 |
Cuthbertson, D.J., U. Alam and A. Tahrani. 2020. COVID-19 and obesity: an opportunity for change. Ther. Adv. Endocrinol. Metab. 11:1-4.
|
6 |
Erridge, C. 2010. Endogenous ligands of TLR2 and TLR4: agonists or assistants?. J. Leukoc. Biol. 87(6):989-999.
DOI
|
7 |
Furuhashi, M., S. Saitoh, K. Shimamoto and T. Miura. 2014. Fatty acid-binding protein 4 (FABP4): pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases. Clin. Med. Insights Cardiol. 8(3): 23-33.
|
8 |
Jeon, Y.H. and S.M. Kang. 2020. The application of Abelmoschus manihot jinhuakui extracts as cosmetic ingredient. J. Converg. Inf. Technol. 10(10):290-297.
DOI
|
9 |
Kawai, T. and S. Akira. 2007. TLR signaling. Semin. Immunol. 19(1):24-32.
DOI
|
10 |
Kopelman, P.G. 2000. Obesity as a medical problem. Nature 404:635-643.
DOI
|
11 |
Roskoski Jr, R. 2012. ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol. Res. 66(2):105-143.
DOI
|
12 |
Seo, H.J. and J.B. Jeong. 2020. Immune-enhancing effects of green lettuce (Lactuca sativa L.) extracts through the TLR4-MAPK/NF-κB signaling pathways in RAW264.7 macrophage cells. Korean J. Plant Res. 33(3):183-193.
DOI
|
13 |
Wang, T. and C. He. 2020. TNF-α and IL-6: The link between immune and bone system. Curr. Drug Targets. 21(3):213-227.
DOI
|
14 |
Weber, A., P. Wasiliew and M. Kracht. 2010. Interleukin-1β (IL-1β) processing pathway. Sci. Signal. 3(105):2.
|
15 |
Zhang, W. and H.T. Liu. 2002. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 12(1):9-18.
DOI
|
16 |
Simu, S.Y., S. Ahn, V. Castro-Aceituno and D.C. Yang. 2017. Ginsenoside Rg5: Rk1 exerts an anti-obesity effect on 3T3-L1 cell line by the downregulation of PPARγ and CEBPα. Iran. J. Biotechnol. 15(4):252.
DOI
|
17 |
Duque, G.A. and A. Descoteaux. 2014. Macrophage cytokines: involvement in immunity and infectious diseases. Front. Immunol. 5:491.
DOI
|
18 |
Hansen, J.S., S. De Mare, H.A. Jones, O. Goransson and K. Lindkvist-Petersson. 2017. Visualization of lipid directed dynamics of perilipin 1 in human primary adipocytes. Sci. Rep. 7(1):1-14.
DOI
|
19 |
Kadowaki, T. and T. Yamauchi. 2005. Adiponectin and adiponectin receptors. Endocr. Rev. 26(3):439-451.
DOI
|
20 |
Kosaraju, R., W. Guesdon, M.J. Crouch, H.L. Teague, E.M. Sullivan, E.A. Karlsson, S.S. Cherry, K. Gowdy, L.C. Bridges, L.R. Reese, P.D. Neufer, M. Armstrong, N. Reisdorph, J.J. Milner, M. Beck and S.R. Shaikh. 2017. B cell activity is impaired in human and mouse obesity and is responsive to an essential fatty acid upon murine influenza infection. J. Immunol. 198(12):4738-4752.
DOI
|
21 |
Seki, E., D.A. Brenner and M. Karin. 2012. A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology 143(2): 307-320.
DOI
|
22 |
Takeda, K. and S. Akira. 2004. TLR signaling pathways. Semin. Immunol. 16(1):3-9.
DOI
|
23 |
Hussain, A., K. Mahawar, Z. Xi., W. Yang and E.H. Shamsi. 2020. Obesity and mortality of COVID-19. Meta-analysis. Obes. Res. Clin. Pract. 14(4):295-300.
DOI
|
24 |
Bogdan, C., M. Rollinghoff and A. Diefenbach. 2000. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr. Opin. Immunol. 12(1):64-76.
DOI
|